Pharmacokinetic/pharmacodynamic studies in drug product development.
作者： Bernd Meibohm , Hartmut Derendorf
DOI: 10.1002/JPS.1167
关键词: Intrinsic activity 、 Drug development 、 Pharmacodynamics 、 Computational biology 、 Drug interaction 、 Drug 、 Pharmacology 、 Medicine 、 Pharmacokinetics 、 Cost effectiveness 、 Clinical trial
摘要: In the quest of ways for rationalizing and accelerating drug product development, integrated pharmacokinetic/pharmacodynamic (PK/PD) concepts provide a highly promising tool. PK/…
sci-hub.se 参考文章(102)
Gerhard Levy, The Case for Preclinical Pharmacodynamics Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development. pp. 7- 13 ,(1993) , 10.1007/978-1-4757-1520-0_2
Martin Schwahn, Nelamangala V. Nagaraja, Hartmut Derendorf, Population pharmacokinetic/pharmacodynamic modeling of cetrorelix, a novel LH-RH antagonist, and testosterone in rats and dogs. Pharmaceutical Research. ,vol. 17, pp. 328- 335 ,(2000) , 10.1023/A:1007557207590
Bernd Meibohm, G. Hochhaus, H. Derendorf, J. Barth, H. Möllmann, Clinical PK/PD modelling as a tool in drug development of corticosteroids. International Journal of Clinical Pharmacology and Therapeutics. ,vol. 35, pp. 481- 488 ,(1997)
Bruno G. Reigner, Peter E.O. Williams, Indra H. Patel, Jean-Louis Steimer, Carl Peck, Peter van Brummelen, An Evaluation of the Integration of Pharmacokinetic and Pharmacodynamic Principles in Clinical Drug Development Experience within Hoffmann La Roche Clinical Pharmacokinectics. ,vol. 33, pp. 142- 152 ,(1997) , 10.2165/00003088-199733020-00005
Virginia D. Schmith, Jill Fiedler‐Kelly, Luann Phillips, Thaddeus H. Grasela, Jr., Prospective use of population pharmacokinetics/pharmacodynamics in the development of cisatracurium. Pharmaceutical Research. ,vol. 14, pp. 91- 97 ,(1997) , 10.1023/A:1012015719694
John Anthony Bauer, Joseph P. Balthasar, Ho‐Leung Fung, Application of Pharmacodynamic Modeling for Designing Time-Variant Dosing Regimens to Overcome Nitroglycerin Tolerance in Experimental Heart Failure Pharmaceutical Research. ,vol. 14, pp. 1140- 1145 ,(1997) , 10.1023/A:1012138320003
Henrik Agersø, William J. Jusko, Lars Ynddal, Jogarao V. S. Gobburu, Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical Research. ,vol. 16, pp. 1412- 1416 ,(1999) , 10.1023/A:1018955126402
Hartmut Derendorf, Bernd Meibohm, Modeling of pharmacokinetic/pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharmaceutical Research. ,vol. 16, pp. 176- 185 ,(1999) , 10.1023/A:1011907920641
Donald Stanski, Jürgen Venitz, Hartmut Derendorf, Robert Powell, Gerald Rhodes, Peter Lee, Philip Chaikin, Raymond Miller, Wayne A. Colburn, Lawrence J. Lesko, Pharmacokinetic/pharmacodynamic modeling in drug research and development. The Journal of Clinical Pharmacology. ,vol. 40, pp. 1399- 1418 ,(2000) , 10.1177/009127000004001211
Robert C. Jackson, A pharmacokinetic-pharmacodynamic model of chemotherapy of human immunodeficiency virus infection that relates development of drug resistance to treatment intensity. Journal of Pharmacokinetics and Biopharmaceutics. ,vol. 25, pp. 713- 730 ,(1997) , 10.1023/A:1025781801322